Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis.
about
Medical Management of Drug-Resistant TuberculosisRespiratory review of 2014: tuberculosis and nontuberculous mycobacterial pulmonary disease.Super-compact treatment with a high dose of moxifloxacin in patients with drug-resistant tuberculosis and its resistance mechanismsComparative efficacy and acceptability of five anti-tubercular drugs in treatment of multidrug resistant tuberculosis: a network meta-analysis.Low Serum Concentrations of Moxifloxacin, Prothionamide, and Cycloserine on Sputum Conversion in Multi-Drug Resistant TB.Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines.Treatment Outcomes with Fluoroquinolone-Containing Regimens for Isoniazid-Resistant Pulmonary TuberculosisMedical treatment of pulmonary multidrug-resistant tuberculosis.Update in tuberculosis and nontuberculous mycobacterial infections 2013.Therapeutic drug monitoring in the treatment of tuberculosis: an update.Antituberculosis drugs in children.Comparing efficacies of moxifloxacin, levofloxacin and gatifloxacin in tuberculosis granulomas using a multi-scale systems pharmacology approach.Pharmacokinetic/pharmacodynamic-based optimization of levofloxacin administration in the treatment of MDR-TB.News on therapeutic management of MDR-tuberculosis: a literature review.Are moxifloxacin and levofloxacin equally effective to treat XDR tuberculosis?Pharmacokinetics of Levofloxacin in Multidrug- and Extensively Drug-Resistant Tuberculosis Patients.Fluoroquinolones in the treatment of tuberculosis: which is best?Treatment of Tuberculosis. A Historical Perspective.Analysis of Green Light Committee implementation and acquisition of second-line drug resistance.Limited Effect of Later-generation Fluoroquinolones in the Treatment of Ofloxacin-resistant and Moxifloxacin-susceptible Multidrug-resistant Tuberculosis.New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development.Choice between Levofloxacin and Moxifloxacin and Multidrug-Resistant Tuberculosis Treatment Outcomes.CT and microbiologic follow-up in primary multidrug-resistant pulmonary tuberculosis.Outcomes of pulmonary MDR-TB: impacts of fluoroquinolone resistance and linezolid treatment.
P2860
Q26801601-5575F424-6A95-4CB9-9178-46C22D02811CQ34440066-5E6E2495-3A4C-4024-8D8C-5D6D3D8617C1Q35159676-3B9596ED-FFCC-49B5-BAAD-2C62AE44779AQ35559180-77F4BD7E-C231-41B8-A490-D11B5B2343F4Q35778303-3084CC01-1E2D-4E66-ABF6-CB086554087AQ36094215-989849F9-323B-48BF-9DA1-B85896A535F9Q36439006-61438175-D76A-46A5-9C43-349E5F909755Q38182982-50D84CB4-B877-4E7A-B574-3F784D24BDC3Q38204777-28FD1038-FF01-40B7-B91C-C0A0A032E27FQ38213320-E3B0F82A-C59C-44CD-897A-C1BABE211FEFQ38533435-1DCF4FFD-71FD-4368-A022-E221C085D1F2Q38619965-8489998C-EFD9-4260-8C3F-B1036E4FB60DQ38845761-39C32AF9-CA8B-4CC9-A8DE-BF06E030B1BEQ39398924-28BC0DCD-42A6-499F-B199-45F646AFB98AQ40202149-C32A262D-B297-4C0A-94B5-30BCDBDC33C1Q40211670-D5AAD7F4-59CD-4E8E-B886-2D60D5D71644Q44398482-69BB6BB1-EE8D-4C08-A0B3-9C029C19D786Q46014832-4C80980E-B432-4E29-9D9C-3C2C60647789Q46046221-AFFF5CA1-1304-4F07-9E11-1A18051A3642Q47371137-D47056C6-52A8-4535-B1BF-2EB3E908FE1CQ47594312-63A4A8E6-AC27-414A-A839-2E65CE43DAADQ47888089-EF721ADB-52F4-4AAF-BD3E-D0192C16457BQ50949896-15FAC739-18E7-426B-90F7-DDD1EB6CF397Q53205517-554A75DA-2289-405B-99F7-DA6FA0181EA7
P2860
Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis.
@en
Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis.
@nl
type
label
Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis.
@en
Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis.
@nl
prefLabel
Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis.
@en
Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis.
@nl
P2093
P2860
P1476
Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis.
@en
P2093
Chang-Hoon Lee
Eun Young Heo
Jae Chol Choi
Jae Ho Lee
Jae-Joon Yim
Ki Hwan Jung
Kwang Ha Yoo
Kyeongman Jeon
P2860
P304
P356
10.1164/RCCM.201303-0604OC
P407
P577
2013-10-01T00:00:00Z